Clinical Trial Update: PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment [Phase 4]

View source ↗

Summary

Phase 4 trial updating the pharmacodynamics and pharmacokinetics of switching between cangrelor and ticagrelor after ticagrelor pretreatment in coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cangrelor (cangrelor)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Florida | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2023-05-16